136 related articles for article (PubMed ID: 34657447)
1. Knockdown of long noncoding RNA AC245100.4 inhibits the tumorigenesis of prostate cancer cells via the STAT3/
Liu C; Lin P; Zhao J; Xie H; Li R; Yang X; Wang N; Jia H; Jiang S; Zhang K; Yu X
Epigenomics; 2021 Oct; 13(20):1591-1605. PubMed ID: 34657447
[TBL] [Abstract][Full Text] [Related]
2. Long non‑coding RNA AC245100.4 promotes prostate cancer tumorigenesis via the microRNA‑145‑5p/RBBP5 axis.
Xie H; Zhao J; Wan J; Zhao J; Wang Q; Yang X; Yang W; Lin P; Yu X
Oncol Rep; 2021 Feb; 45(2):619-629. PubMed ID: 33416179
[TBL] [Abstract][Full Text] [Related]
3. Long non-coding RNA BRE-AS1 represses non-small cell lung cancer cell growth and survival via up-regulating NR4A3.
Zhang M; Wu J; Zhong W; Zhao Z; Liu Z
Arch Biochem Biophys; 2018 Dec; 660():53-63. PubMed ID: 30227111
[TBL] [Abstract][Full Text] [Related]
4. Long non-coding RNA AC245100.4 contributes to prostate cancer migration via regulating PAR2 and activating p38-MAPK pathway.
Liu C; Jiang S; Xie H; Jia H; Li R; Zhang K; Wang N; Lin P; Yu X
Med Oncol; 2022 May; 39(5):94. PubMed ID: 35570225
[TBL] [Abstract][Full Text] [Related]
5. Long non-coding RNA LINC00467 drives hepatocellular carcinoma progression via inhibiting NR4A3.
Wang H; Guo Q; Nampoukime KB; Yang P; Ma K
J Cell Mol Med; 2020 Apr; 24(7):3822-3836. PubMed ID: 32125766
[TBL] [Abstract][Full Text] [Related]
6. LncRNA
Cui R; Liu C; Lin P; Xie H; Wang W; Zhao J; Jiang S; Shi J; Yu X
Epigenomics; 2020 Aug; 12(15):1257-1271. PubMed ID: 32811161
[No Abstract] [Full Text] [Related]
7. Epigenetic silencing of the NR4A3 tumor suppressor, by aberrant JAK/STAT signaling, predicts prognosis in gastric cancer.
Yeh CM; Chang LY; Lin SH; Chou JL; Hsieh HY; Zeng LH; Chuang SY; Wang HW; Dittner C; Lin CY; Lin JM; Huang YT; Ng EK; Cheng AS; Wu SF; Lin J; Yeh KT; Chan MW
Sci Rep; 2016 Aug; 6():31690. PubMed ID: 27528092
[TBL] [Abstract][Full Text] [Related]
8. RP11-495P10.1 promotes HCC cell proliferation by regulating reprogramming of glucose metabolism and acetylation of the NR4A3 promoter via the PDK1/PDH axis.
Liu C; Shi J; Jiang Z; Jiang S; Wu Y; Peng D; Tang J; Guo L
Acta Biochim Biophys Sin (Shanghai); 2024 Jan; 56(1):44-53. PubMed ID: 37905340
[TBL] [Abstract][Full Text] [Related]
9. Transcriptional Profiling of Monocytes Deficient in Nuclear Orphan Receptors
Phelan DE; Shigemura M; Aldhafiri S; Mota C; Hall TJ; Sznajder JI; Murphy EP; Crean D; Cummins EP
Front Immunol; 2021; 12():676644. PubMed ID: 34248958
[TBL] [Abstract][Full Text] [Related]
10. Orphan receptor NR4A3 is a novel target of p53 that contributes to apoptosis.
Fedorova O; Petukhov A; Daks A; Shuvalov O; Leonova T; Vasileva E; Aksenov N; Melino G; Barlev NA
Oncogene; 2019 Mar; 38(12):2108-2122. PubMed ID: 30455429
[TBL] [Abstract][Full Text] [Related]
11. miR-665 expression predicts poor survival and promotes tumor metastasis by targeting NR4A3 in breast cancer.
Zhao XG; Hu JY; Tang J; Yi W; Zhang MY; Deng R; Mai SJ; Weng NQ; Wang RQ; Liu J; Zhang HZ; He JH; Wang HY
Cell Death Dis; 2019 Jun; 10(7):479. PubMed ID: 31209222
[TBL] [Abstract][Full Text] [Related]
12. Matriptase-2/NR4A3 axis switches TGF-β action toward suppression of prostate cancer cell invasion, tumor growth, and metastasis.
Lin HY; Ko CJ; Lo TY; Wu SR; Lan SW; Huang CA; Lin YC; Lin HH; Tu HF; Lee CF; Hsiao PW; Huang HP; Chen MJ; Chang KH; Lee MS
Oncogene; 2022 May; 41(20):2833-2845. PubMed ID: 35418692
[TBL] [Abstract][Full Text] [Related]
13. IL-8 Secreted from M2 Macrophages Promoted Prostate Tumorigenesis via STAT3/MALAT1 Pathway.
Zheng T; Ma G; Tang M; Li Z; Xu R
Int J Mol Sci; 2018 Dec; 20(1):. PubMed ID: 30591689
[TBL] [Abstract][Full Text] [Related]
14. Long non-coding RNA AC245100.4 activates the PI3K/AKT pathway to promote PCa cell proliferation by elevating PAR2.
Zhang K; Liu C; Hu C; Lin P; Qi Q; Jia H; Tang J; Yu X
Heliyon; 2023 Jun; 9(6):e16870. PubMed ID: 37346322
[TBL] [Abstract][Full Text] [Related]
15. Long non‑coding RNA CASC11 interacts with YBX1 to promote prostate cancer progression by suppressing the p53 pathway.
Sun X; Xin S; Zhang Y; Jin L; Liu X; Zhang J; Mei W; Zhang B; Ma W; Ye L
Int J Oncol; 2022 Sep; 61(3):. PubMed ID: 35904175
[TBL] [Abstract][Full Text] [Related]
16. The protective role of NR4A3 in acute myocardial infarction by suppressing inflammatory responses via JAK2-STAT3/NF-κB pathway.
Jiang Y; Feng YP; Tang LX; Yan YL; Bai JW
Biochem Biophys Res Commun; 2019 Oct; 517(4):697-702. PubMed ID: 31399192
[TBL] [Abstract][Full Text] [Related]
17. Radiotherapy in combination with hyperthermia suppresses lung cancer progression via increased NR4A3 and KLF11 expression.
Son B; Jeon J; Lee S; Kim H; Kang H; Youn H; Jo S; Youn B
Int J Radiat Biol; 2019 Dec; 95(12):1696-1707. PubMed ID: 31498019
[No Abstract] [Full Text] [Related]
18. The Orphan Nuclear Receptor NR4A3 Is Involved in the Function of Dendritic Cells.
Nagaoka M; Yashiro T; Uchida Y; Ando T; Hara M; Arai H; Ogawa H; Okumura K; Kasakura K; Nishiyama C
J Immunol; 2017 Oct; 199(8):2958-2967. PubMed ID: 28893954
[TBL] [Abstract][Full Text] [Related]
19. MALAT1 knockdown inhibits prostate cancer progression by regulating miR-140/BIRC6 axis.
Hao T; Wang Z; Yang J; Zhang Y; Shang Y; Sun J
Biomed Pharmacother; 2020 Mar; 123():109666. PubMed ID: 31935634
[TBL] [Abstract][Full Text] [Related]
20. NR4A3 fusion proteins trigger an axon guidance switch that marks the difference between EWSR1 and TAF15 translocated extraskeletal myxoid chondrosarcomas.
Brenca M; Stacchiotti S; Fassetta K; Sbaraglia M; Janjusevic M; Racanelli D; Polano M; Rossi S; Brich S; Dagrada GP; Collini P; Colombo C; Gronchi A; Astolfi A; Indio V; Pantaleo MA; Picci P; Casali PG; Dei Tos AP; Pilotti S; Maestro R
J Pathol; 2019 Sep; 249(1):90-101. PubMed ID: 31020999
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]